1. |
World Health Organization. Global tuberculosis report 2020 [EB/OL] [2020-10-14]. https://www.who.int/teams/global-tuberculosis-programme/tb-reports.
|
2. |
中华人民共和国国国务院办公厅. 国务院办公厅关于印发“十三五”全国结核病防治规划的通知. http://www.gov.cn/zhengce/content/2017-02/16/content_5168491.htm.
|
3. |
Zhang L, Wang F, Wang L, et. al Prevalence of chronic kidney disease in China: across -sectional survey. Lancet, 2012, 379(9818): 815-822.
|
4. |
National Institute for Health and Care Excellence. Guidelines for tuberculosis [EB/OL]. (2016-05-01) [2016-09-12].
|
5. |
World Health Organization. Latent tuberculosis infection [EB/OL]. [2016-09-12].
|
6. |
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis, 2002, 39(2 Suppl 1): S1-S266.
|
7. |
中国防痨协会. 耐药结核病化学治疗指南(2019). 中国防痨杂志, 2019, 41(10): 1025-1073.
|
8. |
中华医学会结核病学分会. 抗结核药物性肝损伤诊治指南(2019 年版). 中华结核和呼吸杂志, 2019, 42(5): 343-356.
|
9. |
Ostermann M, Palchaudhuri P, Riding A, et al. Incidence of tuberculosis is high in chronic kidney disease patients in South East England and drug resistance common. Ren Fail, 2016, 38(2): 256-261.
|
10. |
The National Collaborating Center for Chronic Conditions. Tuberculosis Clinical diagnosis and management of tuberculosis and measures for its prevention and control. London: Royal College of Physicians, 2006.
|
11. |
袁发焕, 光丽霞, 赵生家. 1069 例慢性肾衰患者合并结核病的临床对比研究. 中国现代医学杂志, 2004, 14(20): 1-5, 8.
|
12. |
Yuan FH, Guang LX, Zhao SJ. Clinical comparisons of 1 498 chronic renal failure patients with and without tuberculosis. Ren Fail, 2005, 27: 149-153.
|
13. |
张训, 侯凡凡, 魏冬梅, 等. 慢性肾功能衰竭接受肾替代治疗病人并发结核病. 中华内科学杂志, 1995, 34(10): 666-669.
|
14. |
叶文玲, 李学旺, 李航. 慢性肾功能衰竭血液透析患者合并结核感染的诊治. 中国医学院学报, 2001, 23(5): 535-536.
|
15. |
上海慢性肾脏病早发现及规范化诊治与示范项目专家组, 高翔, 梅长林. 慢性肾脏病筛查诊断及防治指南. 中国实用内科杂志, 2017, 37(1): 28-34.
|
16. |
Romanowski K, Clark EG, Levin A, et al. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int, 2016, 90(1): 34-40.
|
17. |
海珊, 钟慧, 刘芳, 等. 慢性肾脏疾病合并结核 40 例临床分析. 四川医学, 2007, 28(5): 501-502.
|
18. |
Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998–2000. Am J Transplant, 2004, 4: 1523-1528.
|
19. |
Zuo L, Wang M. Current burden and probable increasing incidence of ESRD in China. Clin Nephrol, 2010, 74: S20-S22.
|
20. |
Carrero JJ, Stenvinkel P. Infammation in end-stage renal disease-what have we learned in 10 years?. Semin Dial, 2010, 23: 498-509.
|
21. |
李亮. 从临床医生的角度看结核病诊断技术. 中华临床医师杂志(电子版), 2014, 8(23): 4165-4168.
|
22. |
Al Jahdali H, Ahmed AE, Balkhy HH, et al. Comparison of the tuberculin skin test and Quanti-FERON-TB Gold In-Tube (QFT-G) test for the diagnosis of latent tuberculosis infection in dialysis patients. J Infect Public Health, 2013, 6(3): 166-172.
|
23. |
Ferguson TW, Tangri N, Macdonald K, et al. The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis. Transplantation, 2015, 99: 1084-1091.
|
24. |
陈雪融, 唐小燕. γ-干扰素释放试验研究进展. 现代临床医学, 2016, 42(5): 397-400.
|
25. |
秦庆, 胡瑛, 吕永强. 痰涂片抗酸染色、结核抗体试验、荧光 PCR、T-SPOT.TB 在肺结核诊断中的临床意义. 中国医药科学, 2017, 7(21): 130-133.
|
26. |
贺晨艳, 石海萍, 韩莉, 等. TB-PCR、Xpert MTB/RIF、T-SPOT 释放试验诊断结核感染的临床应用研究. 医学信息上旬刊, 2014, (4): 107-108.
|
27. |
张小刚, 庄玉辉, 何秀云, 等. 重组结核分支杆菌 38kD 和 16kD 蛋白用于结核病血清学诊断的价值. 中国防痨杂志, 2001, 23(5): 281-283.
|
28. |
钱东林. 蛋白芯片检测结核分枝杆菌对肺结核病的临床诊断价值. 标记免疫分析与临床, 2013, 20(5): 352-353.
|
29. |
简奕娈, 古卓云, 魏琳, 等. 抗结核药物性视神经炎的临床分析. 国际眼科杂志, 2014, 14(9): 1705-1706.
|